These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38995264)

  • 1. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013-2023).
    Marshall CM; Federice JG; Bell CN; Cox PB; Njardarson JT
    J Med Chem; 2024 Jul; 67(14):11622-11655. PubMed ID: 38995264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals.
    Vitaku E; Smith DT; Njardarson JT
    J Med Chem; 2014 Dec; 57(24):10257-74. PubMed ID: 25255204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles.
    Delost MD; Smith DT; Anderson BJ; Njardarson JT
    J Med Chem; 2018 Dec; 61(24):10996-11020. PubMed ID: 30024747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of US FDA-Approved Drugs Containing Sulfur Atoms.
    Scott KA; Njardarson JT
    Top Curr Chem (Cham); 2018 Jan; 376(1):5. PubMed ID: 29356979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    de la Torre BG; Albericio F
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures.
    Smith BR; Eastman CM; Njardarson JT
    J Med Chem; 2014 Dec; 57(23):9764-73. PubMed ID: 25255063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.
    Wang S; Yuan XH; Wang SQ; Zhao W; Chen XB; Yu B
    Eur J Med Chem; 2021 Mar; 214():113218. PubMed ID: 33540357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.
    Lang DK; Kaur R; Arora R; Saini B; Arora S
    Anticancer Agents Med Chem; 2020; 20(18):2150-2168. PubMed ID: 32628593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use.
    Benedetto Tiz D; Bagnoli L; Rosati O; Marini F; Sancineto L; Santi C
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022.
    Rizzo C; Amata S; Pibiri I; Pace A; Buscemi S; Palumbo Piccionello A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sulphur-heterocycles in medicinal chemistry: An update.
    Pathania S; Narang RK; Rawal RK
    Eur J Med Chem; 2019 Oct; 180():486-508. PubMed ID: 31330449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.
    Bhutani P; Joshi G; Raja N; Bachhav N; Rajanna PK; Bhutani H; Paul AT; Kumar R
    J Med Chem; 2021 Mar; 64(5):2339-2381. PubMed ID: 33617716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stacking Interactions between 9-Methyladenine and Heterocycles Commonly Found in Pharmaceuticals.
    An Y; Doney AC; Andrade RB; Wheeler SE
    J Chem Inf Model; 2016 May; 56(5):906-14. PubMed ID: 27074615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
    Torre BG; Albericio F
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33504104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective.
    Kumar A; Singh AK; Singh H; Vijayan V; Kumar D; Naik J; Thareja S; Yadav JP; Pathak P; Grishina M; Verma A; Khalilullah H; Jaremko M; Emwas AH; Kumar P
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunable and Cooperative Catalysis for Enantioselective Pictet-Spengler Reaction with Varied Nitrogen-Containing Heterocyclic Carboxaldehydes.
    Chan YC; Sak MH; Frank SA; Miller SJ
    Angew Chem Int Ed Engl; 2021 Nov; 60(46):24573-24581. PubMed ID: 34487418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
    Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
    Ilardi EA; Vitaku E; Njardarson JT
    J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pharmaceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds.
    Liu A; Han J; Nakano A; Konno H; Moriwaki H; Abe H; Izawa K; Soloshonok VA
    Chirality; 2022 Jan; 34(1):86-103. PubMed ID: 34713503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.